S&P 500
(-0.16%) 5 464.62 points
Dow Jones
(0.04%) 39 150 points
Nasdaq
(-0.18%) 17 689 points
Oil
(-0.86%) $80.59
Gas
(-0.80%) $2.72
Gold
(-1.45%) $2 334.70
Silver
(-4.03%) $29.58
Platinum
(1.22%) $996.30
USD/EUR
(0.09%) $0.935
USD/NOK
(0.17%) $10.56
USD/GBP
(0.12%) $0.791
USD/RUB
(2.05%) $89.06

Realtime updates for Guardant Health Inc [GH]

Exchange: NASDAQ Sector: Healthcare Industry: Diagnostics & Research
BUY
60.00%
return -0.96%
SELL
0.00%
return 4.04%
Last Updated21 Jun 2024 @ 16:00

0.00% $ 29.56

BUY 110 min ago

@ $29.85

Issued: 21 Jun 2024 @ 15:30


Return: -0.95%


Previous signal: Jun 21 - 12:58


Previous signal: Sell


Return: -0.42 %

Live Chart Being Loaded With Signals

Commentary (21 Jun 2024 @ 16:00):
Our systems believe the stock currently is undervalued by 0.25% compare to its pairs and should correct upwards.

Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a clinical-genomic liquid biopsy dataset of advanced cancer patients...

Stats
Today's Volume 2.29M
Average Volume 2.38M
Market Cap 3.62B
EPS $-0.940 ( Q1 | 2024-05-09 )
Next earnings date ( $-0.570 ) 2024-08-01
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -7.54
(Sector) 42.63
(Industry) 0
ATR14 $0.655 (2.22%)
ACRS 1.77%
AKU -17.87%
APDN 0.04%
BDSX 6.21%
BIOC 0.00%
BNGO -6.81%
BNR -1.04%
CDNA 0.64%
CEMI 0.22%
CHEK -3.83%
CNTG -9.79%
CSTL 1.52%
DMTK -3.14%
DRIO 11.01%
EXAS 1.93%
FLDM -7.02%
FLGT 1.10%
GENE 3.03%
GH 0.00%
GTH 0.12%
HTGM 0.00%
ICLR 0.88%
IDXX -0.05%
ILMN 0.30%
ISPC -5.86%
LAB 0.52%
LMDX 0.00%
MDXH -1.50%
ME 1.39%
MEDP 0.85%
MYGN 1.93%
MYNZ -19.82%
NDRA 3.04%
NEO 1.23%
NEOG 0.42%
NOTV 4.65%
NTRA -0.08%
OCDX 0.92%
OLK 0.31%
OPGN 2.12%
OPK -1.61%
PMD 2.62%
PRPO -3.30%
PSNL -0.81%
RDNT 2.55%
SERA -6.21%
SHC 3.71%
SQL 0.00%
STIM 2.23%
STRR -2.93%
STRRP 3.89%
SYNH 0.02%
TRIB -0.80%
TTOO 2.95%
TWST 4.58%
VIVO 0.00%
XGN 0.00%
Insider Trading
Date Person Action Amount type
2024-06-15 Tariq Musa Sell 250 Restricted Stock Units
2024-06-15 Tariq Musa Buy 250 Common Stock
2024-06-15 Saia John G. Buy 4 017 Common Stock
2024-06-15 Saia John G. Sell 1 434 Common Stock
2024-06-15 Saia John G. Sell 4 017 Restricted Stock Units
INSIDER POWER
7.07
Last 100 transactions
Buy: 680 676 | Sell: 595 067
Correlation (AI algo v.1.1b): Undervalued: 0.25% $29.64 paired level. (The Algo Track The Changes Of The Most Correlated Stocks In Realtime And Give An Instant Update)

Volume Correlation

Long: -0.49 (neutral)
Short: -0.87 (strong negative)
Signal:(27) Be Aware. Possible trading coming up! (swing)

Guardant Health Inc Correlation

10 Most Positive Correlations
KOSS0.94
MSEX0.89
FTDR0.879
JJSF0.876
FLNC0.87
ALHC0.87
NECB0.867
MYFW0.866
BKSC0.862
RNRG0.855
10 Most Negative Correlations
ARQT-0.863
ELEV-0.831
HQY-0.831
ALRN-0.829
LTRPA-0.823
FAAR-0.819
USOI-0.817
CFSB-0.817
ASND-0.816
JSPR-0.816

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Guardant Health Inc Correlation - Currency/Commodity

The country flag 0.61
( weak )
The country flag 0.43
( neutral )
The country flag 0.00
( neutral )
The country flag 0.77
( moderate )
The country flag -0.05
( neutral )
The country flag -0.56
( weak negative )

Guardant Health Inc Financials

Annual 2023
Revenue: $563.95M
Gross Profit: $336.90M (59.74 %)
EPS: $-4.28
FY 2023
Revenue: $563.95M
Gross Profit: $336.90M (59.74 %)
EPS: $-4.28
FY 2022
Revenue: $449.54M
Gross Profit: $293.21M (65.23 %)
EPS: $-6.41
FY 2021
Revenue: $373.65M
Gross Profit: $250.74M (67.11 %)
EPS: $-4.00

Financial Reports:

No articles found.

Guardant Health Inc Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Guardant Health Inc

Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a clinical-genomic liquid biopsy dataset of advanced cancer patients. It is also developing LUNAR-2 test for the early detection of colorectal cancer in asymptomatic individuals eligible; and GuardantConnect, an integrated software-based solution for clinical and biopharmaceutical customers seeking to connect patients tested with the Guardant360 assay with actionable alterations with potentially relevant clinical trials. In addition, the company offers Guardant Reveal Test for neoadjuvant and adjuvant treatment selection in early-stage cancer patients; Guardant360 tissue genotyping product; and Guardant-19 for use in the detection of the novel coronavirus. Further, it offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, and kits fulfillment related services to biopharmaceutical companies and medical institutions. The company was incorporated in 2011 and is headquartered in Redwood City, California.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Total Execution Time: 1.7927448749542 seconds
Number of API calls: 3
Number of DB calls: 9